Exact Mass: 430.0536

Bicalutamide

C18H14F4N2O4S (430.061)

Bicalutamide is only found in individuals that have used or taken this drug. It is an oral non-steroidal anti-androgen for prostate cancer. It binds to the androgen receptor.Bicalutamide competes with androgen for the binding of androgen receptors, consequently blocking the action of androgens of adrenal and testicular origin which stimulate the growth of normal and malignant prostatic tissue. L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BB - Anti-androgens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Calcium gluconate

C12H22CaO14 (430.0635)

A - Alimentary tract and metabolism > A12 - Mineral supplements > A12A - Calcium > A12AA - Calcium C78275 - Agent Affecting Blood or Body Fluid > C29730 - Electrolyte Replacement Agent D - Dermatologicals

Calcium gluconate

C12H22CaO14 (430.0635)

Food additive: firming agent, sequestrant, stabiliser, texturiser. Anticaking agent in powdered coffee↵↵Calcium gluconate is a mineral supplement. It is the form of calcium most widely used in the treatment of hypocalcemia. Calcium gluconate contains 9.3\\% calcium. It is also used to counteract an overdose of magnesium sulfate, often administered to pregnant women experiencing premature labor to slow or stop contractions. Excess magnesium sulfate can cause respiratory depression, for which calcium gluconate would be the antidote. Food additive: firming agent, sequestrant, stabiliser, texturiser. Anticaking agent in powdered coffee

ZINC12370117

C19H15ClN4O4S (430.0503)

SANGUINARINE SULFATE

C20H16NO8S+ (430.0597)

9-Acetoxymethyl-4,6-diformyl-3,8-dihydroxy-1-methyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carbonsaeure|9-acetoxymethyl-4,6-diformyl-3,8-dihydroxy-1-methyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carboxylic acid

C20H14O11 (430.0536)

Galbinic acid

C20H14O11 (430.0536)

5-{4-[4-(5-pent-1,3-diynylthiophen-2-yl)-but-3-ynyloxy]-but-1-ynyl}-2,2-bithiophene|echinoetherthiophene

C25H18OS3 (430.052)

14-hydroxy-8beta-(3-chloro-2-hydroxyisobutyryloxy)-3-chlorodehydroleucodin|14-hydroxy-8beta-<3-chloro-2-hydroxyisobutyryloxy>-3-chlorodehydroleucodin

C19H20Cl2O7 (430.0586)

Bicalutamide

C18H14F4N2O4S (430.061)

L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BB - Anti-androgens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4405; ORIGINAL_PRECURSOR_SCAN_NO 4401 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4432; ORIGINAL_PRECURSOR_SCAN_NO 4429 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4382; ORIGINAL_PRECURSOR_SCAN_NO 4377 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4426; ORIGINAL_PRECURSOR_SCAN_NO 4422 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4399; ORIGINAL_PRECURSOR_SCAN_NO 4398 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4400; ORIGINAL_PRECURSOR_SCAN_NO 4397 CONFIDENCE standard compound; INTERNAL_ID 2349 CONFIDENCE standard compound; INTERNAL_ID 8615 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2809

h_298_bicalutamide

C18H14F4N2O4S (430.061)

Cys Cys Cys Cys

C12H22N4O5S4 (430.0473)

SNS-314

C18H15ClN6OS2 (430.0437)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

(s)-bicalutamide

C18H14F4N2O4S (430.061)

(R)-Bicalutamide

C18H14F4N2O4S (430.061)

N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(2-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide

C18H14F4N2O4S (430.061)

bis(trifluoromethylsulfonyl)azanide,1-butyl-3-methylpyridin-1-ium

C12H16F6N2O4S2 (430.0456)

Calcium gluconate

2(C6H11O7).Ca (430.0635)

sodium 1-amino-9,10-dihydro-9,10-dioxo-4-o-toluidinoanthracene-2-sulphonate

C21H15N2NaO5S (430.0599)

5-[(2,4-Dinitrophenyl)amino]-2-anilinobenzenesulphonic acid

C18H14N4O7S (430.0583)

Calcium 2,3,4,5,6-pentahydroxyhexanoate

C12H22CaO14 (430.0635)

2-(5-bromothiophen-2-yl)-N-(4-methylpiperazin-1-yl)quinoline-4-carboxamide

C19H19BrN4OS (430.0463)

N-[5-[[2-(2-methyl-2,3-dihydroindol-1-yl)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide

C19H18N4O2S3 (430.0592)

1-(3,4-Dichlorophenyl)-3-[diethoxyphosphoryl(phenyl)methyl]urea

C18H21Cl2N2O4P (430.0616)

ethyl-dTDP

C12H20N2O11P2 (430.0542)

5-[4-({4-[5-(penta-1,3-diyn-1-yl)thiophen-2-yl]but-3-yn-1-yl}oxy)but-1-yn-1-yl]-2,2'-bithiophene

C25H18OS3 (430.052)

9-chloro-6,10-dihydroxy-20-methoxy-2,12,21-trioxahexacyclo[9.9.1.1¹,¹³.1³,⁷.0¹¹,²³.0¹⁷,²²]tricosa-3,5,7(23),13(22),14,16-hexaene-8,18-dione

C21H15ClO8 (430.0455)

(1s,9s,10s,11s,20r)-9-chloro-6,10-dihydroxy-20-methoxy-2,12,21-trioxahexacyclo[9.9.1.1¹,¹³.1³,⁷.0¹¹,²³.0¹⁷,²²]tricosa-3,5,7(23),13(22),14,16-hexaene-8,18-dione

C21H15ClO8 (430.0455)

8-chloro-6-(hydroxymethyl)-9-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 3-chloro-2-hydroxy-2-methylpropanoate

C19H20Cl2O7 (430.0586)

{4-formyl-5,13,17-trihydroxy-7-methyl-9,15-dioxo-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3,5,7,12,14(18)-hexaen-12-yl}methyl acetate

C20H14O11 (430.0536)

7-[(acetyloxy)methyl]-4,15-diformyl-6,14-dihydroxy-12-methyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-5-carboxylic acid

C20H14O11 (430.0536)

(3ar,4r,9ar,9br)-8-chloro-6-(hydroxymethyl)-9-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl (2r)-3-chloro-2-hydroxy-2-methylpropanoate

C19H20Cl2O7 (430.0586)

[(17s)-4-formyl-5,13,17-trihydroxy-7-methyl-9,15-dioxo-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3,5,7,12,14(18)-hexaen-12-yl]methyl acetate

C20H14O11 (430.0536)